Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 2
Submit an article Journal homepage
317
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Significance of analyzing circulating plasma cells in multiple myeloma: differences from measuring minimal residual diseases in bone marrow

Sung-Min Kima Cancer Research Institute, Seoul National University College of Medicine, Seoul, KoreaView further author information
,
Youngeun Leeb Department of Laboratory Medicine, Seoul National University Hospital, Seoul, KoreaView further author information
,
Dajeong Jeongb Department of Laboratory Medicine, Seoul National University Hospital, Seoul, KoreaView further author information
,
Jiwon Yunb Department of Laboratory Medicine, Seoul National University Hospital, Seoul, KoreaORCID Iconhttps://orcid.org/0000-0002-6306-3944View further author information
ORCID Icon,
Sung-Soo Yoonc Department of Internal Medicine, Clinical Research Institute, Seoul National University Hospital, Seoul, KoreaView further author information
,
Sang Mee Hwangd Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam, KoreaView further author information
,
Nuri Leee Department of Laboratory Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, KoreaCorrespondence[email protected]
View further author information
&
Dong Soon Leea Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea;b Department of Laboratory Medicine, Seoul National University Hospital, Seoul, KoreaView further author information
 show all
Pages 487-490 | Received 30 May 2021, Accepted 02 Oct 2021, Published online: 02 Nov 2021

References

  • Ladetto M, Brüggemann M, Monitillo L, et al. Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. Leukemia. 2014;28(6):1299–1307.
  • Dingli D, Nowakowski GS, Dispenzieri A, et al. Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system. Blood. 2006;107(8):3384–3388.
  • Astle JM, Xu ML, Friedman T, et al. Limitations of poor bone marrow aspirations (for an accurate diagnosis) despite the multimodal analytical era: a longitudinal retrospective study. Am J Hematol. 2017;92(10):E600–E602.
  • Riley RS, Hogan TF, Pavot DR, et al. A pathologist’s perspective on bone marrow aspiration and biopsy: I. performing a bone marrow examination. J Clin Lab Anal. 2004;18(2):70–90.
  • Chu B, Bao L, Wang Y, et al. CD27 antigen negative expression indicates poor prognosis in newly diagnosed multiple myeloma. Clin Immun. 2020;213:108363.
  • Guikema JE, Hovenga S, Vellenga E, et al. CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high-risk disease. Br J Haematol. 2003;121(1):36–43.
  • Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene. 2016;35(10):1216–1224.
  • Paiva B, Paino T, Sayagues JM, et al. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile. Blood. 2013;122(22):3591–3598.
  • Hillengass J, Usmani S, Rajkumar SV, et al. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 2019;20(6):e302–e312.
  • Waldmann TA, Strober W. Metabolism of immunoglobulins. Prog Allergy. 1969;13:1–110.
  • Kim J, Hayton WL, Robinson JM, et al. Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model. Clin Immunol. 2007;122(2):146–155.
  • Anderson CL, Chaudhury C, Kim J, et al. Perspective- FcRn transports albumin: relevance to immunology and medicine. Trends Immunol. 2006;27(7):343–348.
  • Nasir B, Nahlah A, Maha A, et al. Discrepancies in serum free light chain assays and immunofixation for response evaluation and prognostication in plasma cell proliferative disorders. Blood. 2011;118(21):5099.
  • Huang RS, Oleske DA, Tholpady A, et al. High false-positive rate for monoclonal gammopathy using capillary electrophoresis (CAPILLARYS 2) alone. J Clin Lab Anal. 2014;28(1):42–46.
  • Paiva B, van Dongen JJ, Orfao A. New criteria for response assessment: role of minimal residual disease in multiple myeloma. Blood. 2015;125(20):3059–3068.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.